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Introduction
The Cre-loxP system is widely used to conditionally delete target genes [1] . This allows circumventing potential embryonic lethality that would result from a constitutive deletion of essential target genes. A critical element of this system is the Cre recombinase, a nuclease encoded by the Cre gene of the bacteriophage P1 [2] . Over the last years, the Cre-loxP based technique has greatly expanded through the availability of Cre expressing mice in which expression is either controlled through cell-or tissue-specific promotor elements, or inducible by administration of certain drugs [3, 4] . Still, there is growing concern that the expression of a protein originating from a different organism might itself, directly or indirectly, interfere with the cellular homeostasis of the targeted tissue or the targeted cell population.
Publications showing that the expression of Cre might cause chromosomal rearrangements, growth arrest or influence gene expression profiles [5] [6] [7] provided first indications for these unwanted side effects. Furthermore, there is data showing that the expression of Cre resulted in the degeneration of neurons e.g. photoreceptor cells accompanied by an impaired neuronal function [8] . Moreover, when using drug based inducible systems, the application of drugs such as tamoxifen can have unwanted side effects, too. In support of this Kim and coworkers reported that tamoxifen exposure leads to cell death of retinal pigment epithelial (RPE) cells through caspase dependent and independent mechanisms [9] .
In the current study we investigated the influence of Cre recombinase expression and topical tamoxifen exposure to neuronal tissues, with the murine retina as an easily accessible model system. For the first time, this study shows comprehensive and comparative data, addressing the retinal morphology and function, glial reactivity, the molecular expression levels of neuroprotective factors, as well as neuronal vulnerability following light induced photoreceptor degeneration. We analyzed three different, widely used transgenic Cre expressing mouse strains and compared Cre expressing or tamoxifen-exposed retinae to control retinae. We used the α-Cre line, the Lmop-Cre line and the tamoxifen inducible
CAGGCre-ER
TM line [10] [11] [12] , all of them having a robust expression of Cre in the entire retina, or certain cellular subpopulations of the retina. In summary, we did not observe Cre recombinase or tamoxifen induced changes in retinal structure and function, glial reactivity, expression of neuroprotective factors or photoreceptor vulnerability in any of the models investigated.
Material and Methods

Mice
All procedures conformed to the tenets of the National Institutes of Health Guidelines on the Care and Use of Animals in Research, the EU Directive 2010/63/E, and institutional guidelines. All mice were albino, homozygous for the L450 variant of RPE65 [13] and reared in 12 h light-12 h dark cycles (lights on at 7 am). Transgenic CAGGCre-ER TM [11] and α-Cre [10] mice were bred in a mixed FVB/N × Balb-c background (F1) and Lmop-Cre [12] were bred in a CD1 x Balb-c background.
Tamoxifen treatment
The Cre recombinase in transgenic CAGGCre-ER TM is inducible. These mice carry the Cre-ER TM fusion protein comprised of the Cre-recombinase protein fused to a mutant form of the mouse estrogen receptor [11] . The fusion protein is restricted to the cytoplasm and Cre-ER TM will only access the nucleus after binding to tamoxifen. We additionally used Balb-c wildtype animals to analyze the influence of tamoxifen treatment only. To this end, tamoxifen (Cayman Chemicals, Ann Arbor, MI, USA) was diluted in corn oil (Sigma-Aldrich Chemie GmbH, Munich, Germany) to a final concentration of 5 mg/ml and the solution was topically applied as eye drops (10 µl/drop) onto the eyes of CAGGCre-ER TM mice and control littermates or Balb-c wildtypes, respectively, three times per day in four hours intervals as described previously [14, 15] . Our treatment started at postnatal day (P) 28 and lasted to P32.
As a side note regarding the use of tamoxifen: we used tamoxifen, not 4OH-tamoxifen, to activate the Cre recombinase in CAGGCre-ER TM animals. Tamoxifen binds to the mutant form of the mouse estrogen receptor with lower affinity than 4OH-tamoxifen [16, 17] .
However, due to the topical application, very high local concentrations are reached, resulting in a successful activation of the Cre recombinase in these animals, as can be seen in Fig. 1 and [11, 14, 15] .
PCR analyses for genotyping
Genotypes were screened by isolating genomic DNA from tail biopsies and testing for transgenic sequences by PCR as described previously [18] . For detection of Cre primer sequences were 5'-ATG CTT CTG TCC GTT TGC CG-3' (sense) and 5'-CCT GTT TTG CAC GTT CAC CG-3' (antisense) and for lacZ genotyping the primer sequences were 5'-ATC CTC TGC ATG GTC AGG TC-3' (sense) and 5'-CGT GGC CTG ATT CAT TCC-3' (antisense). Lmop-Cre)/R26R and R26R mice following a previously published protocol [18] . Paraffin sections (6 µm thick) were analyzed using an Axio Imager Z1 light microscope (Carl Zeiss Microscopy GmbH, Jena, Germany) and the appropriate Axiovision software 4.8 (Carl Zeiss Microscopy GmbH, Jena, Germany).
Microscopy and morphometry
Eyes were isolated, post-fixed for 24 h in modified Karnovsky fixative [20] and embedded in Epon (SERVA Electrophoresis GmbH, Heidelberg, Germany). Semithin sagittal sections (1.0 µm thick) were cut through the eyes and stained after Richardson [21] . Sagittal sections were investigated using an Axio Imager Z1 fluorescent microscope (Carl Zeiss Microscopy GmbH, Jena, Germany) and the appropriate Axiovision software 4.8 (Carl Zeiss Microscopy GmbH, Jena, Germany). Thickness of the outer nuclear layer (ONL) and inner nuclear layer (INL)
were measured on semithin sections along the mid-horizontal (nasal-temporal) plane. Briefly, the distance between ora serrata (OS) and optic nerve head (ONH) was divided into tenths to defined individual measure points. We measured one section per animal and one measurement (INL and ONL) per measure point. The sections were always stretching through the optic nerve head to ensure comparable conditions between the individual sections. Subsequently, ONL or INL thickness was measured at these measure points and the means± SEM of the ONL or INL thickness were plotted in a spider diagram as described in [18, 22] .
Immunohistochemistry
Prior to GFAP staining, eyes were fixed for 4 h in 4% 
Fundus imaging and angiography
Retinal imaging was performed with a commercially available imaging system (Micron III;
Phoenix Research Labs, Pleasanton, CA, USA). Light source path and imaging path filters (low pass and high pass at 500 nm) were used for fluorescein angiography (FLA). Mice were anesthetized by s. c. injection of ketamine (65 mg/kg) and xylazine (13 mg/kg), and their pupils were dilated with tropicamide eyedrops (Mydriaticum Stulln; Pharma Stulln GmbH, Stulln, Germany) before image acquisition. FLA was performed using a s.c. injection of 75 mg/kg body weight fluorescein-Na (ALCON Pharma GmbH, Freiburg, Germany).
RNA analysis
Total RNA from neural retinae was extracted using TRIzol and first strand cDNA synthesis was performed using iScript cDNA Synthesis Kit (Bio-Rad Laboratories GmbH, Munich, Germany) and the ∆∆Ct method in Excel (Microsoft Corporation, Redmond, WA, USA) [24] .
Light damage
To experimentally induce the apoptosis of photoreceptor cells [25] [26] [27] , six to seven weeks old albino mice that were homozygous for the L450 variant of RPE65 [13] were transferred to cyclic dim light (<100 lux) for 5 d followed by a a dark-adapting period of 12 h. Mice were then placed in reflective cages and exposed to diffuse cool, white fluorescent light coming from the top of the cage with an intensity of 5000 lux for 30 min. Average intensity was measured on the cage floor (5000 lux). After light exposure, mice were allowed to recover first for 6 h in dim light and then brought back to normal cyclic light conditions before sacrifice. Light damage experiments were always performed in the early morning.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)
Apoptotic cell death was analyzed by TUNEL labeling using the Apoptosis Detection System (DeadEnd Fluorometric TUNEL, Promega GmbH, Mannheim, Germany). Paraffin sections were treated following manufacturers' instructions and protocols reported previously [18] . For quantitative analysis, the number of TUNEL-positive nuclei in sagittal sections throughout the entire retina was counted using the ImageJ software program and normalized to the area of the ONL [18, 28] .
Statistical analysis
All results are expressed as mean ± standard error of the mean (SEM). Statistical significance was calculated by using a two-tailed Student's t-test. P values ≤ 0.05 were considered to be statistically significant.
Results
To elucidate the potential influence of Cre recombinase expression or topical tamoxifen exposure on the neuronal retina, we compared four groups of mice: (1) Tamoxifen treated wildtype animals (control(TX)) were compared to their untreated wildtype littermates Cre animals (α-Cre) were compared to wildtype littermates (control) and (4) Lmop-Cre animals (Lmop-Cre) were compared to wildtype littermates (control).
Cre recombinase expression and activity
CAGGCre-ER TM /R26R mice carry a Cre-ER TM fusion protein comprised of the Cre recombinase protein fused to a mutant form of the mouse estrogen receptor [11] . The fusion protein is restricted to the cytoplasm and Cre-ER TM will only translocate to the nucleus after binding to tamoxifen. In transgenic α-Cre mice, the Cre recombinase is expressed under the control of the α-enhancer element of the pax6 promotor resulting in an early (embryonic day 10.5) and constitutive expression of Cre in all cells that originate from the inner layer of the optic cup [10] . In transgenic Lmop-Cre animals, the Cre recombinase is constitutively expressed under the control of the murine opsin promotor [12] . Promotor activity starts with a rather weak expression from postnatal day 7, until Cre expression reaches gradually its maximum approximately at the age of six weeks [12] . We used the R26R Cre reporter mice to confirm and to visualize the activity of the Cre recombinase in all three analyzed transgenic Cre expressing mouse lines. In the R26R mouse line, a loxP-flanked DNA segment prevents the expression of a downstream lacZ gene. Consequently, when R26R
mice are crossed to a Cre expressing transgenic mouse line, Cre expression leads to the removal of the loxP-flanked DNA segment resulting in the expression of the lacZ protein in all cells in which Cre had been expressed. Using β-galactosidase staining one can directly visualize the cell population in which Cre recombinase had been active [19] . In CAGGCre-ER TM Cre mice, we observed β-galactosidase staining, indicating lacZ reactivity, throughout the eyes of four weeks old CAGGCre-ER TM /R26R animals after tamoxifen treatment (Fig.1A) .
Notably, in the retina all neuronal layers were stained, as was the retinal pigment epithelium and the adjacent choroid (Fig. 1A) . The control(TX)/R26R littermates did not show any lacZ reaction in the eye, confirming the specificity of the performed β-galactosidase staining.
When lacZ staining was performed in 10 days old transgenic α-Cre mice, the β-galactosidase reaction was restricted to the neuronal layers of the retina and the non-pigmented epithelial layer of the ciliary body and iris while the control/R26R animal did not show any lacZ reaction (Fig. 1B) . As expected, in Lmop-Cre animals, β-galactosidase staining was restricted to the outer plexiform layer, the inner and outer segments of the photoreceptors and appeared rather patchy in the outer nuclear layer at the age of three weeks (Fig. 1C) . Again, the control/R26R animals did not show any β-galactosidase staining (Fig. 1C) .
Cre recombinase expression or tamoxifen treatment do not change retinal morphology and function
To investigate, whether the expression of Cre or topical tamoxifen exposure might influence retinal morphology, we analyzed semithin section of six to ten weeks old animals. We did not observe overt structural differences in any of the three investigated transgenic Cre expressing mouse lines (CAGGCre-ER TM , α-Cre line and Lmop-Cre line), nor in the tamoxifen treated control(TX) animals, compared to their respective controls. All investigated eyes were well developed and showed a regular neuronal architecture ( Fig. 2A, D , G, J), as well as a regular retinal vasculature, determined by in vivo fluorescence angiography (Fig 3A, B, C). To conduct a detailed morphometric analysis, we measured the thickness of the inner nuclear layer (INL) and the outer nuclear layer (ONL). The mean values of the thickness at individual measure points were plotted in a spider diagram followed by statistical evaluation.
Here, we could not detect any statistically significant differences between experimental (Cre expressing and/or tamoxifen-treated) and control mice (INL: Fig. 2B , E, H, K; ONL: Fig. 2C (Fig. 4) . ERG analyses showed similar waveforms for both, the dark and light adapted responses of the CAGGCre-ER TM and control(TX) animals (Fig. 4) . The a-and b-wave amplitudes ( Fig. 4A and B) and implicit times ( (Fig. 5B) . Furthermore, we did not observe any statistically significant differences comparing control retinae to tamoxifen treated control(TX) retinae (Fig. 5B) . To exclude the possibility that expression of Cre or tamoxifen exposure would result in reactivity of Müller cells or astrocytes, we used immunohistochemical staining for glial fibrillary acidic marker protein (GFAP). Since mature retinal astrocytes do express GFAP [32, 33] , we observed an intense immunoreactivity for GFAP in the RGC layer, exactly where the retinal astrocytes are located. However, the overall intensity of GFAP and the astrocyte cell morphology did not differ between control or transgenic animals, indicating the resting astrocyte population [33, 34] . Furthermore, we did not detect the characteristic radial stripes throughout the retina that would indicate a reactivity of Müller cells (Fig. 6A , C, E) [35] . Moreover, we used realtime RT-PCR analysis to screen the retinae for Gfap mRNA expression levels, but we did not detect any significant differences in its expression levels (Fig. 6B, D, F) . 
Cre recombinase expression or tamoxifen treatment do not influence the expression of neuroprotective factors
Next, we analyzed whether the expression of Cre or tamoxifen exposure might interfere with the expression levels of certain neuroprotective factors. Here we focused on leukemia inhibitory factor (Lif), endothelin 2 (Edn2) and fibroblast growth factor 2 (Fgf2), as these factors are well known to play a major role in retinal neuroprotective signaling cascades [36] [37] [38] [39] . Using realtime RT-PCR analysis we could not detect any significant differences in the expression levels of the investigated factors in all three transgenic Cre mouse strains 
7A, C, D)
. Furthermore, we did not observe any statistically significant differences when control retinae were compared with tamoxifen treated control(TX) retinae (Fig. 7B ).
Cre recombinase expression or tamoxifen treatment do not alter neuronal vulnerability
We next examined whether the expression of Cre or tamoxifen exposure might have an influence on the vulnerability of neurons following experimentally induced damage. Here we focused on the photoreceptor cells and used the light damage as a model to induce photoreceptor degeneration through apoptosis. We labeled the apoptotic photoreceptor cells in the light exposed animals by using the 'terminal deoxynucleotidyl transferase dUTP nick end labeling' (TUNEL) method (Fig. 8) . Subsequently, we counted the total number of TUNEL positive cells and normalized this number to the area of the ONL (Fig. 8C, F, I ). In the following statistical evaluation, we could not detect any statistically significant differences However, the eye is an immune privileged organ with a high level of transforming growth factor (TGF)-β2, contributing to the quiescence of microglia and Müller cells [30, 42, 43, 45, 46] .
This raises the possibility that the high level of TGF-β2 counteracts a potential cellular reactivity of these cells upon the ectopic expression of Cre or tamoxifen exposure.
Consequently, we cannot exclude the possibility that this situation might be different in other, less immune-privileged organs. Our group and others recently showed that upon Müller cells reactivity, as evidenced by elevated expression levels of Gfap, the mRNA levels of neuroprotective factors like Edn2, Lif and Fgf2 were induced in the retina [27, 44, [47] [48] [49] . In this study, however, we did not observe changes in Gfap levels and conclusively we could also not detect any statistically significant differences in the expression of these factors, whether Cre or tamoxifen exposure was present or not.
The expression of Cre recombinase might pose especially problematic for photoreceptors, because they are more prone to become apoptotic as soon as their cellular homeostasis is disturbed. This could be due to genetic disease mutations [50, 51] , or the expression of a foreign protein like Cre. Moreover, there is accumulating evidence that the expression of mutated or exogenous proteins in glial cells, resulting in dysregulated glial cell function, can increase the vulnerability of neuronal cells (see for example [52] [53] [54] ). This gives rise to the possibility that the ectopic expression of Cre in neurons or glial cells might also increase the vulnerability of neurons. To test this possibility, we used the light damage model to induce neuronal apoptosis of photoreceptor cells [25, 27, 55, 56] . Our data shows no statistically significant differences in the number of apoptotic neurons after light induced neuronal damage, independent of the presence of Cre.
There is evidence in the literature that tamoxifen treatment itself has unwanted side effects, e.g. cell death of retinal pigment epithelial (RPE) cells through caspase dependent and independent mechanisms [9] . Based on our results, we can exclude such potential side effects regarding an altered neuronal vulnerability, at least for the tamoxifen concentration and the application route used in our study.
In summary, we conclude that the Cre-loxP system and its induction through tamoxifen is a safe and reliable method to delete desired target genes in the neuronal retina. Neither the expression of Cre, nor tamoxifen exposure itself, interferes with the maintenance of the neuronal tissues regarding neuronal morphology, function, the expression of molecular markers and neuronal vulnerability, as well as the reactivity of macro-and microglia cells.
Our study might therefore reassure neuroscientists in using this method in the future. We 
